|
1
|
Andersen BL, Yang HC, Farrar WB,
Golden-Kreutz DM, Emery CF, Thornton LM, Young DC and Carson WE
III: Psychologic intervention improves survival for breast cancer
patients: A randomized clinical trial. Cancer. 113:3450–3458. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chida Y, Hamer M, Wardle J and Steptoe A:
Do stress-related psychosocial factors contribute to cancer
incidence and survival? Nat Clin Pract Oncol. 5:466–475. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim-Fuchs C, Le CP, Pimentel MA,
Shackleford D, Ferrari D, Angst E, Hollande F and Sloan E: Chronic
stress accelerates pancreatic cancer growth and invasion: A
critical role for beta-adrenergic signaling in the pancreatic
microenvironment. Brain Behav Immun. 40:40–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sloan EK, Priceman SJ, Cox BF, Yu S,
Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas
BD, Wu L, et al: The sympathetic nervous system induces a
metastatic switch in primary breast cancer. Cancer Res.
70:7042–7052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Powell ND, Tarr AJ and Sheridan JF:
Psychosocial stress and inflammation in cancer. Brain Behav Immun.
30 Suppl:S41–S47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beck IM, Vanden Berghe W, Vermeulen L,
Yamamoto KR, Haegeman G and De Bosscher K: Crosstalk in
inflammation: The interplay of glucocorticoid receptor-based
mechanisms and kinases and phosphatases. Endocr Rev. 30:830–882.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin KT and Wang LH: New dimension of
glucocorticoids in cancer treatment. Steroids. 111:84–88. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rutz HP: Effects of corticosteroid use on
treatment of solid tumours. Lancet. 360:1969–1970. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kriegler AB, Bernardo D and Verschoor SM:
Protection of murine bone marrow by dexamethasone during cytotoxic
chemotherapy. Blood. 83:65–71. 1994.PubMed/NCBI
|
|
10
|
Herr I, Ucur E, Herzer K, Okouoyo S,
Ridder R, Krammer PH, von Knebel Doeberitz M and Debatin KM:
Glucocorticoid cotreatment induces apoptosis resistance toward
cancer therapy in carcinomas. Cancer Res. 63:3112–3120.
2003.PubMed/NCBI
|
|
11
|
Sui M, Chen F, Chen Z and Fan W:
Glucocorticoids interfere with therapeutic efficacy of paclitaxel
against human breast and ovarian xenograft tumors. Int J Cancer.
119:712–717. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang C, Beckermann B, Kallifatidis G, Liu
Z, Rittgen W, Edler L, Büchler P, Debatin KM, Büchler MW, Friess H
and Herr I: Corticosteroids induce chemotherapy resistance in the
majority of tumour cells from bone, brain, breast, cervix, melanoma
and neuroblastoma. Int J Oncol. 29:1295–1301. 2006.PubMed/NCBI
|
|
13
|
Zhang C, Marmé A, Wenger T, Gutwein P,
Edler L, Rittgen W, Debatin KM, Altevogt P, Mattern J and Herr I:
Glucocorticoid-mediated inhibition of chemotherapy in ovarian
carcinomas. Int J Oncol. 28:551–558. 2006.PubMed/NCBI
|
|
14
|
Schoneveld OJ, Gaemers IC and Lamers WH:
Mechanisms of glucocorticoid signalling. Biochim Biophys Acta.
1680:114–128. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Herr I, Gassler N, Friess H and Büchler
MW: Regulation of differential pro- and anti-apoptotic signaling by
glucocorticoids. Apoptosis. 12:271–291. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Warny M, Keates AC, Keates S, Castagliuolo
I, Zacks JK, Aboudola S, Qamar A, Pothoulakis C, LaMont JT and
Kelly CP: p38 MAP kinase activation by Clostridium difficile toxin
A mediates monocyte necrosis, IL-8 production and enteritis. J Clin
Invest. 105:1147–1156. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paul A, Wilson S, Belham CM, Robinson CJ,
Scott PH, Gould GW and Plevin R: Stress-activated protein kinases:
Activation, regulation and function. Cell Signal. 9:403–410. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zaidel-Bar R and Geiger B: The switchable
integrin adhesome. J Cell Sci. 123:1385–1388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ponta H, Sherman L and Herrlich PA: CD44:
From adhesion molecules to signalling regulators. Nat Rev Mol Cell
Biol. 4:33–45. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hynes RO: Integrins: Bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Winograd-Katz SE, Fässler R, Geiger B and
Legate KR: The integrin adhesome: From genes and proteins to human
disease. Nat Rev Mol Cell Biol. 15:273–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zaidel-Bar R, Itzkovitz S, Ma'ayan A,
Iyengar R and Geiger B: Functional atlas of the integrin adhesome.
Nat Cell Biol. 9:858–867. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ahadome SD, Zhang C, Tannous E, Shen J and
Zheng JJ: Small-molecule inhibition of Wnt signaling abrogates
dexamethasone-induced phenotype of primary human trabecular
meshwork cells. Exp Cell Res. 357:116–123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guller S, Wozniak R, Leibman MI and
Lockwood CJ: Negative regulation of placental fibronectin
expression by glucocorticoids and cyclic adenosine
3′,5′-monophosphate. Ann N Y Acad Sci. 734:132–142. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dobos J, Kenessey I, Tímár J and Ladányi
A: Glucocorticoid receptor expression and antiproliferative effect
of dexamethasone on human melanoma cells. Pathol Oncol Res.
17:729–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Banciu M, Metselaar JM, Schiffelers RM and
Storm G: Liposomal glucocorticoids as tumor-targeted
anti-angiogenic nanomedicine in B16 melanoma-bearing mice. J
Steroid Biochem Mol Biol. 111:101–110. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lai S, Piras F, Spiga S, Perra MT, Minerba
L, Piga M, Mura E, Murtas D, Demurtas P, Corrias M, et al: Nestin
and vimentin colocalization affects the subcellular location of
glucocorticoid receptor in cutaneous melanoma. Histopathology.
62:487–498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakagawa Y, Nakayama H, Nagata M, Yoshida
R, Kawahara K, Hirosue A, Tanaka T, Yuno A, Matsuoka Y, Kojima T,
et al: Overexpression of fibronectin confers cell adhesion-mediated
drug resistance (CAM-DR) against 5-FU in oral squamous cell
carcinoma cells. Int J Oncol. 44:1376–1384. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schmidt S and Friedl P: Interstitial cell
migration: Integrin-dependent and alternative adhesion mechanisms.
Cell Tissue Res. 339:83–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leiss M, Beckmann K, Girós A, Costell M
and Fässler R: The role of integrin binding sites in fibronectin
matrix assembly in vivo. Curr Opin Cell Biol. 20:502–507. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li XP, Zhang XW, Zheng LZ and Guo WJ:
Expression of CD44 in pancreatic cancer and its significance. Int J
Clin Exp Pathol. 8:6724–6731. 2015.PubMed/NCBI
|
|
32
|
McFarlane S, McFarlane C, Montgomery N,
Hill A and Waugh DJ: CD44-mediated activation of α5β1-integrin,
cortactin and paxillin signaling underpins adhesion of basal-like
breast cancer cells to endothelium and fibronectin-enriched
matrices. Oncotarget. 6:36762–36773. 2015.PubMed/NCBI
|
|
33
|
Clark AS, West K, Streicher S and Dennis
PA: Constitutive and inducible Akt activity promotes resistance to
chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol
Cancer Ther. 1:707–717. 2002.PubMed/NCBI
|
|
34
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Valles SL, Benlloch M, Rodriguez ML, Mena
S, Pellicer JA, Asensi M, Obrador E and Estrela JM: Stress hormones
promote growth of B16-F10 melanoma metastases: An interleukin 6-
and glutathione-dependent mechanism. J Transl Med. 11:722013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Collinson FJ, Lam TK, Bruijn WM, de Wilt
JH, Lamont M, Thompson JF and Kefford RF: Long-term survival and
occasional regression of distant melanoma metastases after adrenal
metastasectomy. Ann Surg Oncol. 15:1741–1749. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Flaherty DC, Deutsch GB, Kirchoff DD, Lee
J, Huynh KT, Lee DY, Foshag LJ, Bilchik AJ and Faries MB:
Adrenalectomy for metastatic melanoma: Current role in the age of
nonsurgical treatments. Am Surg. 81:1005–1009. 2015.PubMed/NCBI
|
|
39
|
McKeown-Longo PJ and Etzler CA: Induction
of fibronectin matrix assembly in human fibrosarcoma cells by
dexamethasone. J Cell Biol. 104:601–610. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nimmer D, Bergtrom G, Hirano H and Amrani
DL: Regulation of plasma fibronectin biosynthesis by
glucocorticoids in chick hepatocyte cultures. J Biol Chem.
262:10369–10375. 1987.PubMed/NCBI
|
|
41
|
Oliver N, Newby RF, Furcht LT and
Bourgeois S: Regulation of fibronectin biosynthesis by
glucocorticoids in human fibrosarcoma cells and normal fibroblasts.
Cell. 33:287–296. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zollinger AJ and Smith ML: Fibronectin,
the extracellular glue. Matrix Biol. 60-61:1–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Benbrook DM and Masamha CP: The
pro-survival function of Akt kinase can be overridden or altered to
contribute to induction of apoptosis. Curr Cancer Drug Targets.
11:586–599. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Onodera Y, Teramura T, Takehara T and
Fukuda K: Hyaluronic acid regulates a key redox control factor Nrf2
via phosphorylation of Akt in bovine articular chondrocytes. FEBS
Open Bio. 5:476–484. 2015. View Article : Google Scholar : PubMed/NCBI
|
